ArticleEJHaem2022

Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.

Loretta J Nastoupil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.